Michael Maris, MD, specializes in the treatment of patients with blood cancers as well as expertise in the use of blood and marrow transplantation for hematologic malignancies.
Dr. Maris is the research director for the Colorado Blood Cancer Institute.
He received his medical degree from the University of Pennsylvania. He completed his internal medicine residency at the Oregon Health Sciences University in Portland, Ore. Dr. Maris completed his oncology and blood and marrow transplantation fellowship at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle, Wash. Dr. Maris' research focus at that time was expanding the role of allogeneic transplantation to older and infirm patients through the use of nonmyeloablative allogeneic hematopoietic stem cell transplantation. Dr. Maris has published extensively in this area.
Dr. Maris' current research interests are in further optimizing allogeneic hematopoietic transplantation for patients of all types as well as the development of novel drug and drug regimens for the treatment of the patients with acute myeloid leukemia. Dr. Maris has extensive experience as an investigator in multiple clinical trials and Dr. Maris has expertise in the treatment of patients with acute myeloid leukemia.
He believes that physicians are educators/guides during the cancer treatment process and patients should be empowered with the knowledge to guide their decisions. Patient understanding of the underlying disease process and therapeutic options is a requirement in the shared clinical decision making between the patient and his/her physician.
University of Pennsylvania School of Medicine
Oregon Health & Science University Hospital
Hutchinson Cancer Research Center/University of Washington
Colorado Blood Cancer Institute
1721 E 19th Ave
Suites 200 & 300
Denver, CO 80218
Phone: (720) 754-4800
Fax: (866) 341-6984